{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:01:41Z","timestamp":1791900101741,"version":"4.3.4"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10072-025-08403-4","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T06:38:37Z","timestamp":1755585517000},"page":"5591-5605","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Beyond Neuroinflammation: Microglia at the Crossroads of Amyloid, Tau, and Neurodegeneration in Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0991-7752","authenticated-orcid":false,"given":"Rasoul","family":"Ebrahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Bordbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazal","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin","family":"Davoody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MahSima","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5349-9285","authenticated-orcid":false,"given":"Khadijeh","family":"Esmaeilpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"issue":"1","key":"8403_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01656-9","volume":"17","author":"M Rosende-Roca","year":"2025","unstructured":"Rosende-Roca M, Garc\u00eda-Guti\u00e9rrez F, Cantero-Fortiz Y, Alegret M, Pytel V, Ca\u00f1abate P et al (2025) Exploring sex differences in Alzheimer\u2019s disease: a comprehensive analysis of a large patient cohort from a memory unit. Alzheimers Res Ther 17(1):27","journal-title":"Alzheimers Res Ther"},{"key":"8403_CR2","doi-asserted-by":"crossref","unstructured":"(2021) Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2021;17(3):327\u2013406","DOI":"10.1002\/alz.12328"},{"key":"8403_CR3","doi-asserted-by":"publisher","first-page":"1418939","DOI":"10.3389\/fimmu.2024.1418939","volume":"15","author":"Z Liao","year":"2024","unstructured":"Liao Z, Zhang Q, Ren N, Zhao H, Zheng X (2024) Progress in mitochondrial and omics studies in Alzheimer\u2019s disease research: from molecular mechanisms to therapeutic interventions. Front Immunol 15:1418939","journal-title":"Front Immunol"},{"issue":"7844","key":"8403_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-020-03160-0","volume":"590","author":"PS Minhas","year":"2021","unstructured":"Minhas PS, Latif-Hernandez A, McReynolds MR, Durairaj AS, Wang Q, Rubin A et al (2021) Restoring metabolism of myeloid cells reverses cognitive decline in ageing. Nature 590(7844):122\u2013128","journal-title":"Nature"},{"issue":"7","key":"8403_CR5","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/biom14070833","volume":"14","author":"Z Sun","year":"2024","unstructured":"Sun Z, Zhang X, So K-F, Jiang W, Chiu K (2024) Targeting microglia in Alzheimer\u2019s disease: pathogenesis and potential therapeutic strategies. Biomolecules 14(7):833","journal-title":"Biomolecules"},{"key":"8403_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020279","author":"D Dias","year":"2025","unstructured":"Dias D, Socodato R (2025) Beyond amyloid and tau: the critical role of microglia in Alzheimer\u2019s disease therapeutics. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines13020279","journal-title":"Biomedicines"},{"issue":"9","key":"8403_CR7","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","volume":"27","author":"TA Pascoal","year":"2021","unstructured":"Pascoal TA, Benedet AL, Ashton NJ, Kang MS, Therriault J, Chamoun M et al (2021) Microglial activation and Tau propagate jointly across Braak stages. Nat Med 27(9):1592\u20131599","journal-title":"Nat Med"},{"issue":"8","key":"8403_CR8","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/s41590-023-01558-2","volume":"24","author":"M-J Dolan","year":"2023","unstructured":"Dolan M-J, Therrien M, Jereb S, Kamath T, Gazestani V, Atkeson T et al (2023) Exposure of iPSC-derived human microglia to brain substrates enables the generation and manipulation of diverse transcriptional states in vitro. Nat Immunol 24(8):1382\u20131390","journal-title":"Nat Immunol"},{"issue":"1","key":"8403_CR9","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1038\/s41598-024-52311-0","volume":"14","author":"G Ramaswami","year":"2024","unstructured":"Ramaswami G, Yuva-Aydemir Y, Akerberg B, Matthews B, Williams J, Golczer G et al (2024) Transcriptional characterization of iPSC-derived microglia as a model for therapeutic development in neurodegeneration. Sci Rep 14(1):2153","journal-title":"Sci Rep"},{"issue":"6","key":"8403_CR10","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.stem.2025.03.009","volume":"32","author":"JP Chadarevian","year":"2025","unstructured":"Chadarevian JP, Davtyan H, Chadarevian AL, Nguyen J, Capocchi JK, Le L et al (2025) Harnessing human iPSC-microglia for CNS-wide delivery of disease-modifying proteins. Cell Stem Cell 32(6):914\u201334e8","journal-title":"Cell Stem Cell"},{"key":"8403_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12112468","author":"L Li","year":"2024","unstructured":"Li L, Sun B, Harris OA, Luo J (2024) TGF-\u03b2 signaling in microglia: a key regulator of development, homeostasis and reactivity. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12112468","journal-title":"Biomedicines"},{"key":"8403_CR12","doi-asserted-by":"publisher","first-page":"1231706","DOI":"10.3389\/fragi.2023.1231706","volume":"4","author":"SF Darwish","year":"2023","unstructured":"Darwish SF, Elbadry AMM, Elbokhomy AS, Salama GA, Salama RM (2023) The dual face of microglia (M1\/M2) as a potential target in the protective effect of nutraceuticals against neurodegenerative diseases. Front Aging 4:1231706","journal-title":"Front Aging"},{"issue":"5","key":"8403_CR13","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/s41380-024-02413-y","volume":"29","author":"T Komori","year":"2024","unstructured":"Komori T, Okamura K, Ikehara M, Yamamuro K, Endo N, Okumura K et al (2024) Brain-derived neurotrophic factor from microglia regulates neuronal development in the medial prefrontal cortex and its associated social behavior. Mol Psychiatry 29(5):1338\u20131349","journal-title":"Mol Psychiatry"},{"issue":"6477","key":"8403_CR14","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1126\/science.aax6752","volume":"367","author":"C Cser\u00e9p","year":"2020","unstructured":"Cser\u00e9p C, P\u00f3sfai B, L\u00e9n\u00e1rt N, Fekete R, L\u00e1szl\u00f3 ZI, Lele Z et al (2020) Microglia monitor and protect neuronal function through specialized somatic purinergic junctions. Science 367(6477):528\u2013537","journal-title":"Science"},{"issue":"6478","key":"8403_CR15","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1126\/science.aaz2288","volume":"367","author":"C Wang","year":"2020","unstructured":"Wang C, Yue H, Hu Z, Shen Y, Ma J, Li J et al (2020) Microglia mediate forgetting via complement-dependent synaptic elimination. Science 367(6478):688\u2013694","journal-title":"Science"},{"key":"8403_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05095-x","author":"R Ebrahimi","year":"2025","unstructured":"Ebrahimi R, Faramarzi A, Salarvandian S, Zarei R, Heidari M, Salehian F, Esmaeilpour K (2025) Melatonin supplementation in Alzheimer\u2019s disease: the potential role in neurogenesis. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-05095-x","journal-title":"Mol Neurobiol"},{"issue":"4","key":"8403_CR17","doi-asserted-by":"publisher","first-page":"705","DOI":"10.4103\/1673-5374.322423","volume":"17","author":"J Cornell","year":"2022","unstructured":"Cornell J, Salinas S, Huang HY, Zhou M (2022) Microglia regulation of synaptic plasticity and learning and memory. Neural Regen Res 17(4):705\u2013716","journal-title":"Neural Regen Res"},{"issue":"1\u20132","key":"8403_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1440-1681.2000.03200.x","volume":"27","author":"G Halliday","year":"2000","unstructured":"Halliday G, Robinson SR, Shepherd C, Kril J (2000) Alzheimer\u2019s disease and inflammation: a review of cellular and therapeutic mechanisms. Clin Exp Pharmacol Physiol 27(1\u20132):1\u20138","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"8403_CR19","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s12035-014-8657-1","volume":"50","author":"F Brosseron","year":"2014","unstructured":"Brosseron F, Krauthausen M, Kummer M, Heneka MT (2014) Body fluid cytokine levels in mild cognitive impairment and Alzheimer\u2019s disease: a comparative overview. Mol Neurobiol 50(2):534\u2013544","journal-title":"Mol Neurobiol"},{"issue":"6","key":"8403_CR20","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1073\/pnas.94.6.2642","volume":"94","author":"B Kaltschmidt","year":"1997","unstructured":"Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C (1997) Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with alzheimer disease. Proc Natl Acad Sci U S A 94(6):2642\u20132647","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"8403_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cytogfr.2011.02.003","volume":"22","author":"MF Neurath","year":"2011","unstructured":"Neurath MF, Finotto S (2011) IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev 22(2):83\u201389","journal-title":"Cytokine Growth Factor Rev"},{"key":"8403_CR22","doi-asserted-by":"crossref","unstructured":"Rao A, Chen N, Kim MJ, Blumenfeld J, Yip O, Liang Z, et al. (2025) Microglia depletion reduces human neuronal APOE4-related pathologies in a chimeric Alzheimer\u2019s disease model. Cell Stem Cell 32(1):86\u2013104.e7","DOI":"10.1016\/j.stem.2024.10.005"},{"issue":"8063","key":"8403_CR23","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41586-025-08852-z","volume":"641","author":"K Kimura","year":"2025","unstructured":"Kimura K, Subramanian A, Yin Z, Khalilnezhad A, Wu Y, He D et al (2025) Immune checkpoint TIM-3 regulates microglia and Alzheimer\u2019s disease. Nature 641(8063):718\u2013731","journal-title":"Nature"},{"issue":"5","key":"8403_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11011-025-01631-9","volume":"40","author":"R Ebrahimi","year":"2025","unstructured":"Ebrahimi R, Shahrokhi Nejad S, Falah Tafti M, Karimi Z, Sadr SR, Ramadhan Hussein D, Talebian N, Esmaeilpour K (2025) Microglial activation as a hallmark of neuroinflammation in Alzheimer\u2019s disease. Metab Brain Dis 40(5):207. https:\/\/doi.org\/10.1007\/s11011-025-01631-9","journal-title":"Metab Brain Dis"},{"issue":"1","key":"8403_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13041-024-01118-1","volume":"17","author":"A Azargoonjahromi","year":"2024","unstructured":"Azargoonjahromi A (2024) The duality of amyloid-\u03b2: its role in normal and Alzheimer\u2019s disease States. Mol Brain 17(1):44","journal-title":"Mol Brain"},{"issue":"5","key":"8403_CR26","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1007\/s12035-023-03736-7","volume":"61","author":"W Tsering","year":"2024","unstructured":"Tsering W, Prokop S (2024) Neuritic plaques - gateways to understanding Alzheimer\u2019s disease. Mol Neurobiol 61(5):2808\u20132821","journal-title":"Mol Neurobiol"},{"issue":"6","key":"8403_CR27","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00401-020-02198-8","volume":"140","author":"BDC Boon","year":"2020","unstructured":"Boon BDC, Bulk M, Jonker AJ, Morrema THJ, van den Berg E, Popovic M et al (2020) The coarse-grained plaque: a divergent A\u03b2 plaque-type in early-onset alzheimer\u2019s disease. Acta Neuropathol 140(6):811\u2013830","journal-title":"Acta Neuropathol"},{"key":"8403_CR28","unstructured":"Malampati S, Stavrides P, Im E, Goulbourne CN, Mohan PS, Das BC et al Pharmacological reacidification of lysosomes attenuates intraneuronal amyloidosis, early neuron death, and amyloid plaque formation in 5xFAD mice. LID - e095538."},{"issue":"2309","key":"8403_CR29","volume":"481","author":"AV Kuznetsov","year":"2025","unstructured":"Kuznetsov AV (2025) A criterion characterizing accumulated neurotoxicity of A\u03b2 oligomers in Alzheimer\u2019s disease. Proc R Soc Lond A Math Phys Eng Sci 481(2309):20240652","journal-title":"Proc R Soc Lond A Math Phys Eng Sci"},{"issue":"5","key":"8403_CR30","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/BF00310142","volume":"81","author":"HM Wisniewski","year":"1991","unstructured":"Wisniewski HM, Barcikowska M, Kida E (1991) Phagocytosis of beta\/A4 amyloid fibrils of the neuritic neocortical plaques. Acta Neuropathol 81(5):588\u2013590","journal-title":"Acta Neuropathol"},{"issue":"3","key":"8403_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF00227813","volume":"84","author":"J Frackowiak","year":"1992","unstructured":"Frackowiak J, Wisniewski HM, Wegiel J, Merz GS, Iqbal K, Wang KC (1992) Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils. Acta Neuropathol 84(3):225\u2013233","journal-title":"Acta Neuropathol"},{"issue":"5","key":"8403_CR32","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1007\/s10787-024-01550-8","volume":"32","author":"S Kaur","year":"2024","unstructured":"Kaur S, Sharma KM, Giridharan A, Dandekar VV (2024) Brain resident microglia in alzheimer\u2019s disease: foe or friends. Inflammopharmacology 32(5):2781\u20132800","journal-title":"Inflammopharmacology"},{"key":"8403_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105404","author":"R Sanchez-Varo","year":"2022","unstructured":"Sanchez-Varo R, Mejias-Ortega M, Fernandez-Valenzuela JJ, Nu\u00f1ez-Diaz C, Caceres-Palomo L, Vegas-Gomez L et al (2022) Transgenic mouse models of Alzheimer\u2019s disease: an integrative analysis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23105404","journal-title":"Int J Mol Sci"},{"key":"8403_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2024.578342","volume":"390","author":"S Fruhw\u00fcrth","year":"2024","unstructured":"Fruhw\u00fcrth S, Zetterberg H, Paludan SR (2024) Microglia and amyloid plaque formation in Alzheimer\u2019s disease - evidence, possible mechanisms, and future challenges. J Neuroimmunol 390:578342","journal-title":"J Neuroimmunol"},{"issue":"11","key":"8403_CR35","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/nn.2432","volume":"12","author":"SA Grathwohl","year":"2009","unstructured":"Grathwohl SA, K\u00e4lin RE, Bolmont T, Prokop S, Winkelmann G, Kaeser SA et al (2009) Formation and maintenance of alzheimer\u2019s disease beta-amyloid plaques in the absence of microglia. Nat Neurosci 12(11):1361\u20131363","journal-title":"Nat Neurosci"},{"key":"8403_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104956","volume":"142","author":"BT Casali","year":"2020","unstructured":"Casali BT, MacPherson KP, Reed-Geaghan EG, Landreth GE (2020) Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies. Neurobiol Dis 142:104956","journal-title":"Neurobiol Dis"},{"key":"8403_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0366-9","volume":"12","author":"NN Dagher","year":"2015","unstructured":"Dagher NN, Najafi AR, Kayala KM, Elmore MR, White TE, Medeiros R et al (2015) Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice. J Neuroinflammation 12:139","journal-title":"J Neuroinflammation"},{"key":"8403_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110961","author":"S Kiani Shabestari","year":"2022","unstructured":"Kiani Shabestari S, Morabito S, Danhash EP, McQuade A, Sanchez JR, Miyoshi E et al (2022) Absence of microglia promotes diverse pathologies and early lethality in Alzheimer\u2019s disease mice. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2022.110961","journal-title":"Cell Rep"},{"issue":"1","key":"8403_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41232-025-00383-4","volume":"45","author":"S Takatori","year":"2025","unstructured":"Takatori S, Kondo M, Tomita T (2025) Unraveling the complex role of microglia in Alzheimer\u2019s disease: amyloid \u03b2 metabolism and plaque formation. Inflamm Regen 45(1):16","journal-title":"Inflamm Regen"},{"issue":"2","key":"8403_CR40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/glia.24465","volume":"72","author":"J Ni","year":"2024","unstructured":"Ni J, Xie Z, Quan Z, Meng J, Qing H (2024) How brain \u2018cleaners\u2019 fail: mechanisms and therapeutic value of microglial phagocytosis in alzheimer\u2019s disease. Glia 72(2):227\u2013244","journal-title":"Glia"},{"issue":"1","key":"8403_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41593-021-00951-0","volume":"25","author":"P d\u2019Errico","year":"2022","unstructured":"d\u2019Errico P, Ziegler-Waldkirch S, Aires V, Hoffmann P, Mez\u00f6 C, Erny D et al (2022) Microglia contribute to the propagation of A\u03b2 into unaffected brain tissue. Nat Neurosci 25(1):20\u201325","journal-title":"Nat Neurosci"},{"issue":"3","key":"8403_CR42","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/psp4.13095","volume":"13","author":"C Weathered","year":"2024","unstructured":"Weathered C, Bardehle S, Yoon C, Kumar N, Leyns CEG, Kennedy ME et al (2024) Microglial roles in Alzheimer\u2019s disease: an agent-based model to elucidate microglial spatiotemporal response to beta-amyloid. CPT Pharmacometrics Syst Pharmacol 13(3):449\u2013463","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"19","key":"8403_CR43","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1093\/hmg\/ddaa209","volume":"29","author":"W Liu","year":"2020","unstructured":"Liu W, Taso O, Wang R, Bayram S, Graham AC, Garcia-Reitboeck P et al (2020) Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions. Hum Mol Genet 29(19):3224\u20133248","journal-title":"Hum Mol Genet"},{"issue":"2","key":"8403_CR44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J et al (2013) Variant of TREM2 associated with the risk of alzheimer\u2019s disease. N Engl J Med 368(2):107\u2013116","journal-title":"N Engl J Med"},{"issue":"1","key":"8403_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13024-018-0262-8","volume":"13","author":"PJ Cheng-Hathaway","year":"2018","unstructured":"Cheng-Hathaway PJ, Reed-Geaghan EG, Jay TR, Casali BT, Bemiller SM, Puntambekar SS et al (2018) The Trem2 R47H variant confers loss-of-function-like phenotypes in alzheimer\u2019s disease. Mol Neurodegener 13(1):29","journal-title":"Mol Neurodegener"},{"key":"8403_CR46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1073\/pnas.2100356118","volume":"118","author":"KM Schoch","year":"2021","unstructured":"Schoch KM, Ezerskiy LA, Morhaus MM, Bannon RN, Sauerbeck AD, Shabsovich M et al (2021) Acute Trem2 reduction triggers increased microglial phagocytosis, slowing amyloid deposition in mice. Proc Natl Acad Sci U S A 118:27","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8403_CR47","doi-asserted-by":"crossref","unstructured":"Wang S, Sudan R, Peng V, Zhou Y, Du S, Yuede CM et al (2022) TREM2 drives microglia response to amyloid-\u03b2 via SYK-dependent and -independent pathways. Cell 185(22):4153-69.e19","DOI":"10.1016\/j.cell.2022.09.033"},{"issue":"5","key":"8403_CR48","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41590-021-00913-5","volume":"22","author":"Y Huang","year":"2021","unstructured":"Huang Y, Happonen KE, Burrola PG, O\u2019Connor C, Hah N, Huang L et al (2021) Microglia use TAM receptors to detect and engulf amyloid \u03b2 plaques. Nat Immunol 22(5):586\u2013594","journal-title":"Nat Immunol"},{"issue":"11","key":"8403_CR49","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.immuni.2024.09.014","volume":"57","author":"S Kaji","year":"2024","unstructured":"Kaji S, Berghoff SA, Spieth L, Schlaphoff L, Sasmita AO, Vitale S et al (2024) Apolipoprotein E aggregation in microglia initiates alzheimer\u2019s disease pathology by seeding \u03b2-amyloidosis. Immunity 57(11):2651\u201368e12","journal-title":"Immunity"},{"issue":"1","key":"8403_CR50","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12974-024-03143-2","volume":"21","author":"X Hou","year":"2024","unstructured":"Hou X, Qu X, Chen W, Sang X, Ye Y, Wang C et al (2024) CD36 deletion prevents white matter injury by modulating microglia polarization through the Traf5-MAPK signal pathway. J Neuroinflammation 21(1):148","journal-title":"J Neuroinflammation"},{"key":"8403_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2024.102877","volume":"86","author":"RM Beiter","year":"2024","unstructured":"Beiter RM, Sheehan PW, Schafer DP (2024) Microglia phagocytic mechanisms: development informing disease. Curr Opin Neurobiol 86:102877","journal-title":"Curr Opin Neurobiol"},{"issue":"12","key":"8403_CR52","doi-asserted-by":"publisher","first-page":"13075","DOI":"10.1096\/fj.201900439","volume":"33","author":"C Venegas","year":"2019","unstructured":"Venegas C, Heneka MT (2019) Inflammasome-mediated innate immunity in Alzheimer\u2019s disease. FASEB J 33(12):13075\u201313084","journal-title":"FASEB J"},{"key":"8403_CR53","doi-asserted-by":"crossref","unstructured":"Wu Y, Eisel UL (2023) Microglia-astrocyte communication in alzheimer\u2019s disease. J Alzheimers Dis. (Preprint):1\u201319","DOI":"10.3233\/JAD-230199"},{"key":"8403_CR54","doi-asserted-by":"crossref","unstructured":"Li S, Wang J, Guo Q, Bai Y, Liu W, Hodgetts KJ et al (2025) Impairment of hippocampal long-term potentiation by soluble amyloid-\u03b2 oligomers is mediated by glutamate transporter 1 expressed in neurons. Neural Regen Res","DOI":"10.4103\/NRR.NRR-D-24-00882"},{"issue":"7701","key":"8403_CR55","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-018-0023-4","volume":"556","author":"A-C Wendeln","year":"2018","unstructured":"Wendeln A-C, Degenhardt K, Kaurani L, Gertig M, Ulas T, Jain G et al (2018) Innate immune memory in the brain shapes neurological disease hallmarks. Nature 556(7701):332\u2013338","journal-title":"Nature"},{"key":"8403_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13030240","author":"MD Rippee-Brooks","year":"2024","unstructured":"Rippee-Brooks MD, Wu W, Dong J, Pappolla M, Fang X, Bao X (2024) Viral infections, are they a trigger and risk factor of Alzheimer\u2019s disease? Pathogens. https:\/\/doi.org\/10.3390\/pathogens13030240","journal-title":"Pathogens"},{"issue":"33","key":"8403_CR57","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf5808","volume":"9","author":"S Fruhw\u00fcrth","year":"2023","unstructured":"Fruhw\u00fcrth S, Reinert LS, \u00d6berg C, Sakr M, Henricsson M, Zetterberg H et al (2023) TREM2 is down-regulated by HSV1 in microglia and involved in antiviral defense in the brain. Sci Adv 9(33):eadf5808","journal-title":"Sci Adv"},{"issue":"4","key":"8403_CR58","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1172\/JCI133737","volume":"130","author":"ER Roy","year":"2020","unstructured":"Roy ER, Wang B, Wan YW, Chiu G, Cole A, Yin Z et al (2020) Type I interferon response drives neuroinflammation and synapse loss in alzheimer disease. J Clin Invest 130(4):1912\u20131930","journal-title":"J Clin Invest"},{"key":"8403_CR59","doi-asserted-by":"crossref","unstructured":"McManus RM, Komes MP, Griep A, Santarelli F, Schwartz S, Ram\u00f3n Perea J et al (2025) NLRP3-mediated glutaminolysis controls microglial phagocytosis to promote Alzheimer\u2019s disease progression. Immunity 58(2):326\u2009\u2013\u200943.e11","DOI":"10.1016\/j.immuni.2025.01.007"},{"key":"8403_CR60","doi-asserted-by":"crossref","unstructured":"Colom-Cadena M, Davies C, Sirisi S, Lee JE, Simzer EM, Tzioras M et al (2023) Synaptic oligomeric tau in Alzheimer\u2019s disease - A potential culprit in the spread of tau pathology through the brain. Neuron 111(14):2170-83.e6","DOI":"10.1016\/j.neuron.2023.04.020"},{"issue":"1","key":"8403_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01665-8","volume":"17","author":"Z Sheng","year":"2025","unstructured":"Sheng Z, Wang L, Chen M, Zhong F, Wu S, Liang S et al (2025) Cerebrospinal fluid \u03b22-microglobulin promotes the Tau pathology through microglia-astrocyte communication in alzheimer\u2019s disease. Alzheimers Res Ther 17(1):2","journal-title":"Alzheimers Res Ther"},{"key":"8403_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081800","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Liu B, Wang J, Xu L, Yu S, Fu J et al (2022) A\u03b2 and Tau regulate microglia metabolism via exosomes in Alzheimer\u2019s disease. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10081800","journal-title":"Biomedicines"},{"issue":"1","key":"8403_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00825-0","volume":"20","author":"ES Jung","year":"2025","unstructured":"Jung ES, Choi H, Mook-Jung I (2025) Decoding microglial immunometabolism: a new frontier in Alzheimer\u2019s disease research. Mol Neurodegener 20(1):37","journal-title":"Mol Neurodegener"},{"key":"8403_CR64","doi-asserted-by":"publisher","first-page":"1508023","DOI":"10.3389\/fimmu.2025.1508023","volume":"16","author":"J Fu","year":"2025","unstructured":"Fu J, Wang R, He J, Liu X, Wang X, Yao J et al (2025) Pathogenesis and therapeutic applications of microglia receptors in Alzheimer\u2019s disease. Front Immunol 16:1508023","journal-title":"Front Immunol"},{"issue":"11","key":"8403_CR65","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1001\/jamaneurol.2023.3530","volume":"80","author":"RN Taddei","year":"2023","unstructured":"Taddei RN, Perbet R, Mate de Gerando A, Wiedmer AE, Sanchez-Mico M, Connors Stewart T et al (2023) Tau oligomer-containing synapse elimination by microglia and astrocytes in Alzheimer disease. JAMA Neurol 80(11):1209\u20131221","journal-title":"JAMA Neurol"},{"key":"8403_CR66","doi-asserted-by":"crossref","unstructured":"Taddei R, Perbet R, Mate de Gerando A, Wiedmer A, Sanchez-Mico MV, Stewart T et al (2023) Tau Oligomer\u2013Containing synapse elimination by microglia and astrocytes in alzheimer disease. JAMA Neurol 80","DOI":"10.1001\/jamaneurol.2023.3530"},{"key":"8403_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acc.2025.01.005","volume":"126","author":"S Chinnathambi","year":"2025","unstructured":"Chinnathambi S, Rangappa N, Chandrashekar M (2025) Internalization of extracellular Tau oligomers in Alzheimer\u2019s disease. Adv Clin Chem 126:1\u201329","journal-title":"Adv Clin Chem"},{"issue":"6","key":"8403_CR68","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.14336\/AD.2023.0327","volume":"14","author":"G Forloni","year":"2023","unstructured":"Forloni G (2023) Oligomers and neurodegeneration: new evidence. Aging Dis 14(6):1977\u20131980","journal-title":"Aging Dis"},{"issue":"1","key":"8403_CR69","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12974-018-1309-z","volume":"15","author":"SC Hopp","year":"2018","unstructured":"Hopp SC, Lin Y, Oakley D, Roe AD, DeVos SL, Hanlon D et al (2018) The role of microglia in processing and spreading of bioactive Tau seeds in alzheimer\u2019s disease. J Neuroinflammation 15(1):269","journal-title":"J Neuroinflammation"},{"issue":"7728","key":"8403_CR70","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","volume":"562","author":"TJ Bussian","year":"2018","unstructured":"Bussian TJ, Aziz A, Meyer CF, Swenson BL, van Deursen JM, Baker DJ (2018) Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature 562(7728):578\u2013582","journal-title":"Nature"},{"issue":"7","key":"8403_CR71","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK et al (2017) A unique microglia type associated with restricting development of alzheimer\u2019s disease. Cell 169(7):1276\u201390e17","journal-title":"Cell"},{"issue":"9","key":"8403_CR72","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.neurol.2018.07.001","volume":"174","author":"GU H\u00f6glinger","year":"2018","unstructured":"H\u00f6glinger GU, Respondek G, Kovacs GG (2018) New classification of tauopathies. Rev Neurol (Paris) 174(9):664\u2013668","journal-title":"Rev Neurol (Paris)"},{"key":"8403_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-47","volume":"9","author":"N Zilka","year":"2012","unstructured":"Zilka N, Kazmerova Z, Jadhav S, Neradil P, Madari A, Obetkova D et al (2012) Who fans the flames of alzheimer\u2019s disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways. J Neuroinflammation 9:47","journal-title":"J Neuroinflammation"},{"issue":"1","key":"8403_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1310-6","volume":"15","author":"SM Bemiller","year":"2018","unstructured":"Bemiller SM, Maphis NM, Formica SV, Wilson GN, Miller CM, Xu G et al (2018) Genetically enhancing the expression of chemokine domain of CX(3)CL1 fails to prevent Tau pathology in mouse models of Tauopathy. J Neuroinflammation 15(1):278","journal-title":"J Neuroinflammation"},{"key":"8403_CR75","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fnins.2015.00196","volume":"9","author":"N Maphis","year":"2015","unstructured":"Maphis N, Xu G, Kokiko-Cochran ON, Cardona AE, Ransohoff RM, Lamb BT et al (2015) Loss of tau rescues inflammation-mediated neurodegeneration. Front Neurosci 9:196","journal-title":"Front Neurosci"},{"issue":"9","key":"8403_CR76","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.celrep.2017.07.082","volume":"20","author":"JH Tseng","year":"2017","unstructured":"Tseng JH, Xie L, Song S, Xie Y, Allen L, Ajit D et al (2017) The deacetylase HDAC6 mediates endogenous neuritic Tau pathology. Cell Rep 20(9):2169\u20132183","journal-title":"Cell Rep"},{"issue":"4","key":"8403_CR77","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1002\/alz.13699","volume":"20","author":"SM Rossano","year":"2024","unstructured":"Rossano SM, Johnson AS, Smith A, Ziaggi G, Roetman A, Guzman D et al (2024) Microglia measured by TSPO PET are associated with Alzheimer\u2019s disease pathology and mediate key steps in a disease progression model. Alzheimers Dement 20(4):2397\u20132407","journal-title":"Alzheimers Dement"},{"key":"8403_CR78","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.neurobiolaging.2021.06.020","volume":"106","author":"H Zhang","year":"2021","unstructured":"Zhang H, Wang H, Gao F, Yang J, Xu Y, Fu Y et al (2021) Tspo deficiency accelerates amyloid pathology and neuroinflammation by impairing microglial phagocytosis. Neurobiol Aging 106:292\u2013303","journal-title":"Neurobiol Aging"},{"issue":"2","key":"8403_CR79","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3233\/JAD-230239","volume":"95","author":"E Conti","year":"2023","unstructured":"Conti E, Grana D, Angiulli F, Karantzoulis A, Villa C, Combi R et al (2023) TSPO modulates oligomeric amyloid-\u03b2-induced monocyte chemotaxis: relevance for neuroinflammation in Alzheimer\u2019s disease. J Alzheimers Dis 95(2):549\u2013559","journal-title":"J Alzheimers Dis"},{"key":"8403_CR80","doi-asserted-by":"crossref","unstructured":"Cao Y, Tang K, Ma P, Zhang R, Yang Y, Li T et al (2025) The role of peripheral innate immune cells in alzheimer\u2019s disease progression. Front Immunol 16\u20132025","DOI":"10.3389\/fimmu.2025.1616939"},{"issue":"4","key":"8403_CR81","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1159\/000492596","volume":"65","author":"L Zhao","year":"2019","unstructured":"Zhao L (2019) CD33 in alzheimer\u2019s disease - biology, pathogenesis, and therapeutics: a mini-review. Gerontology 65(4):323\u2013331","journal-title":"Gerontology"},{"issue":"17","key":"8403_CR82","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1093\/hmg\/ddaa179","volume":"29","author":"A Griciuc","year":"2020","unstructured":"Griciuc A, Federico AN, Natasan J, Forte AM, McGinty D, Nguyen H et al (2020) Gene therapy for Alzheimer\u2019s disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation. Hum Mol Genet 29(17):2920\u20132935","journal-title":"Hum Mol Genet"},{"issue":"10","key":"8403_CR83","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1093\/brain\/awz241","volume":"142","author":"R Mancuso","year":"2019","unstructured":"Mancuso R, Fryatt G, Cleal M, Obst J, Pipi E, Monz\u00f3n-Sandoval J et al (2019) Csf1r inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice. Brain 142(10):3243\u20133264","journal-title":"Brain"},{"key":"8403_CR84","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200785","author":"S Wang","year":"2020","unstructured":"Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H et al (2020) Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20200785","journal-title":"J Exp Med"},{"issue":"3","key":"8403_CR85","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s12035-017-0467-9","volume":"55","author":"J Yin","year":"2018","unstructured":"Yin J, Zhao F, Chojnacki JE, Fulp J, Klein WL, Zhang S et al (2018) Nlrp3 inflammasome inhibitor ameliorates amyloid pathology in a mouse model of Alzheimer\u2019s disease. Mol Neurobiol 55(3):1977\u20131987","journal-title":"Mol Neurobiol"},{"issue":"6","key":"8403_CR86","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s12031-020-01489-9","volume":"70","author":"VD Chavali","year":"2020","unstructured":"Chavali VD, Agarwal M, Vyas VK, Saxena B (2020) Neuroprotective effects of ethyl pyruvate against aluminum chloride-induced alzheimer\u2019s disease in rats via inhibiting toll-like receptor 4. J Mol Neuroscience: MN 70(6):836\u2013850","journal-title":"J Mol Neuroscience: MN"},{"issue":"1","key":"8403_CR87","doi-asserted-by":"publisher","first-page":"7028","DOI":"10.1038\/s41467-024-51163-6","volume":"15","author":"ND Schartz","year":"2024","unstructured":"Schartz ND, Liang HY, Carvalho K, Chu SH, Mendoza-Arvilla A, Petrisko TJ et al (2024) C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an alzheimer\u2019s disease mouse model. Nat Commun 15(1):7028","journal-title":"Nat Commun"},{"issue":"6","key":"8403_CR88","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23045","volume":"36","author":"Y Yang","year":"2022","unstructured":"Yang Y, Guo L, Wang J, Li W, Zhou X, Zhang C et al (2022) Arglabin regulates microglia polarization to relieve neuroinflammation in Alzheimer\u2019s disease. J Biochem Mol Toxicol 36(6):e23045","journal-title":"J Biochem Mol Toxicol"},{"issue":"3","key":"8403_CR89","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1385\/JMN:23:3:205","volume":"23","author":"L Guo","year":"2004","unstructured":"Guo L, LaDu MJ, Van Eldik LJ (2004) A dual role for Apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity. J Mol Neurosci 23(3):205\u2013212","journal-title":"J Mol Neurosci"},{"issue":"49","key":"8403_CR90","doi-asserted-by":"publisher","first-page":"19276","DOI":"10.1523\/JNEUROSCI.3487-13.2013","volume":"33","author":"T Kanekiyo","year":"2013","unstructured":"Kanekiyo T, Cirrito JR, Liu CC, Shinohara M, Li J, Schuler DR et al (2013) Neuronal clearance of amyloid-\u03b2 by endocytic receptor LRP1. J Neurosci 33(49):19276\u201319283","journal-title":"J Neurosci"},{"issue":"4","key":"8403_CR91","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland TK, Song WM, Huang SC, Ulrich JD, Sergushichev A, Beatty WL et al (2017) TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease. Cell 170(4):649","journal-title":"Cell"},{"issue":"1","key":"8403_CR92","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0006-8993(94)91386-2","volume":"656","author":"DA DeWitt","year":"1994","unstructured":"DeWitt DA, Richey PL, Praprotnik D, Silver J, Perry G (1994) Chondroitin sulfate proteoglycans are a common component of neuronal inclusions and astrocytic reaction in neurodegenerative diseases. Brain Res 656(1):205\u2013209","journal-title":"Brain Res"},{"key":"8403_CR93","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.bcp.2017.12.021","volume":"151","author":"E Adinolfi","year":"2018","unstructured":"Adinolfi E, Giuliani AL, De Marchi E, Pegoraro A, Orioli E, Di Virgilio F (2018) The P2X7 receptor: a main player in inflammation. Biochem Pharmacol 151:234\u2013244","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"8403_CR94","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41386-019-0502-9","volume":"45","author":"A Bhattacharya","year":"2020","unstructured":"Bhattacharya A, Ceusters M (2020) Targeting neuroinflammation with brain penetrant P2X7 antagonists as novel therapeutics for neuropsychiatric disorders. Neuropsychopharmacology 45(1):234\u2013235","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"8403_CR95","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00401-013-1242-2","volume":"127","author":"B Brawek","year":"2014","unstructured":"Brawek B, Schwendele B, Riester K, Kohsaka S, Lerdkrai C, Liang Y et al (2014) Impairment of in vivo calcium signaling in amyloid plaque-associated microglia. Acta Neuropathol 127(4):495\u2013505","journal-title":"Acta Neuropathol"},{"issue":"2","key":"8403_CR96","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1007\/s12035-023-03628-w","volume":"61","author":"X Lu","year":"2024","unstructured":"Lu X, Zhan L, Chai G, Chen M, Sun W, Xu E (2024) Hypoxic preconditioning attenuates neuroinflammation via inhibiting NF-\u03baB\/NLRP3 axis mediated by p-MLKL after transient global cerebral ischemia. Mol Neurobiol 61(2):1080\u20131099","journal-title":"Mol Neurobiol"},{"issue":"7","key":"8403_CR97","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12089","volume":"10","author":"H Su","year":"2021","unstructured":"Su H, Rustam YH, Masters CL, Makalic E, McLean CA, Hill AF et al (2021) Characterization of brain-derived extracellular vesicle lipids in Alzheimer\u2019s disease. J Extracell Vesicles 10(7):e12089","journal-title":"J Extracell Vesicles"},{"issue":"5","key":"8403_CR98","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.ymthe.2021.01.020","volume":"29","author":"K Dooley","year":"2021","unstructured":"Dooley K, McConnell RE, Xu K, Lewis ND, Haupt S, Youniss MR et al (2021) A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties. Mol Ther 29(5):1729\u20131743","journal-title":"Mol Ther"},{"key":"8403_CR99","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neuroscience.2014.10.029","volume":"302","author":"V Porrini","year":"2015","unstructured":"Porrini V, Lanzillotta A, Branca C, Benarese M, Parrella E, Lorenzini L et al (2015) CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid. Neuroscience 302:112\u2013120","journal-title":"Neuroscience"},{"issue":"2","key":"8403_CR100","doi-asserted-by":"publisher","first-page":"149","DOI":"10.14283\/jpad.2018.18","volume":"5","author":"AH Burstein","year":"2018","unstructured":"Burstein AH, Sabbagh M, Andrews R, Valcarce C, Dunn I, Altstiel L (2018) Development of azeliragon, an oral small molecule antagonist of the receptor for advanced glycation endproducts, for the potential slowing of loss of cognition in mild Alzheimer\u2019s disease. J Prev Alzheimers Dis 5(2):149\u2013154","journal-title":"J Prev Alzheimers Dis"},{"issue":"4","key":"8403_CR101","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/cbf.3623","volume":"39","author":"J Xue","year":"2021","unstructured":"Xue J, Jia P, Zhang D, Yao Z (2021) TTP488 ameliorates NLRP3-associated inflammation, viability, apoptosis, and ROS production in an Alzheimer\u2019s disease cell model by mediating the JAK1\/STAT3\/NF\u03baB\/IRF3 pathway. Cell Biochem Funct 39(4):555\u2013561","journal-title":"Cell Biochem Funct"},{"issue":"22","key":"8403_CR102","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1212\/WNL.0b013e3181a18691","volume":"72","author":"JC Breitner","year":"2009","unstructured":"Breitner JC, Haneuse SJ, Walker R, Dublin S, Crane PK, Gray SL et al (2009) Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort. Neurology 72(22):1899\u20131905","journal-title":"Neurology"},{"key":"8403_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-92","volume":"8","author":"M Song","year":"2011","unstructured":"Song M, Jin J, Lim JE, Kou J, Pattanayak A, Rehman JA et al (2011) TLR4 mutation reduces microglial activation, increases A\u03b2 deposits and exacerbates cognitive deficits in a mouse model of alzheimer\u2019s disease. J Neuroinflammation 8:92","journal-title":"J Neuroinflammation"},{"issue":"1","key":"8403_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-020-0559-8","volume":"13","author":"Q Zhong","year":"2020","unstructured":"Zhong Q, Zou Y, Liu H, Chen T, Zheng F, Huang Y et al (2020) Toll-like receptor 4 deficiency ameliorates \u03b22-microglobulin induced age-related cognition decline due to neuroinflammation in mice. Mol Brain 13(1):20","journal-title":"Mol Brain"},{"issue":"3","key":"8403_CR105","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/eji.201545855","volume":"46","author":"S Shi","year":"2016","unstructured":"Shi S, Liang D, Chen Y, Xie Y, Wang Y, Wang L et al (2016) Gx-50 reduces \u03b2-amyloid-induced TNF-\u03b1, IL-1\u03b2, NO, and PGE2 expression and inhibits NF-\u03baB signaling in a mouse model of alzheimer\u2019s disease. Eur J Immunol 46(3):665\u2013676","journal-title":"Eur J Immunol"},{"issue":"7-8","key":"8403_CR106","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1002\/jcp.29452","volume":"235","author":"N Dong","year":"2020","unstructured":"Dong N, Li X, Xue C, Zhang L, Wang C, Xu X et al (2020) Astragalus polysaccharides alleviates LPS\u2010induced inflammation via the NF\u2010\u03baB\/MAPK signaling pathway. J Cell Physiol 235(7\u20138):5525\u20135540","journal-title":"J Cell Physiol"},{"issue":"1","key":"8403_CR107","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13195-021-00843-2","volume":"13","author":"ND Prins","year":"2021","unstructured":"Prins ND, Harrison JE, Chu HM, Blackburn K, Alam JJ, Scheltens P (2021) A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild alzheimer\u2019s disease. Alzheimers Res Ther 13(1):106","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"8403_CR108","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1021\/acscentsci.2c01369","volume":"9","author":"SH Son","year":"2023","unstructured":"Son SH, Lee NR, Gee MS, Song CW, Lee SJ, Lee SK et al (2023) Chemical knockdown of phosphorylated p38 mitogen-activated protein kinase (MAPK) as a novel approach for the treatment of alzheimer\u2019s disease. ACS Cent Sci 9(3):417\u2013426","journal-title":"ACS Cent Sci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08403-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08403-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08403-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:01:49Z","timestamp":1760983309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08403-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":108,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["8403"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08403-4","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"No Competing interest is declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}